metricas
covid
Buscar en
Gastroenterología y Hepatología
Toda la web
Inicio Gastroenterología y Hepatología Epidemiología de la enfermedad inflamatoria intestinal crónica en Gijón. Astu...
Journal Information
Vol. 24. Issue 5.
Pages 228-235 (January 2001)
Share
Share
Download PDF
More article options
Vol. 24. Issue 5.
Pages 228-235 (January 2001)
Full text access
Epidemiología de la enfermedad inflamatoria intestinal crónica en Gijón. Asturias
Epidemiology of chronic inflammatory bowel disease in gijÓn, asturias (spain)
Visits
11474
C. Saro Gismera
Corresponding author
csarog@meditex.es

Correspondencia: Dra. C. Saro Gismera. Servicio de Aparato Digestivo. Hospital de Cabueñes. Camino de Cabueñes, s/n. 33394 Gijón. Asturias.
, G. Argüelles Fernández, C.A. Navascues, R.García López, A.Suárez González, G.Díaz Álvarez, A.Palacios Galán, A.González Bernal, A. Martínez
M. Lacort Fernándeza, J. Antón Magarzob, A. Altadill Arreguic, F. Vizosoc
a Servicio de Aparato Digestivo. UCI.Hospital de Cabueñes
b Servicio de Aparato Digestivo. Servicio de Cirugía. Hospital de Cabueñes
c Servicio de Aparato Digestivo. Hospital de Jove. Gijón. Asturias
This item has received
Article information
Objetivo

Conocer los distintos aspectos epidemiológicos de la enfermedad inflamatoria intestinal crónica. Para ello se han analizado la distribución de las enfermedades que la componen, el sexo y la edad en el momento diagnóstico, y se han valorado el tiempo de latencia, los criterios empleados para el diagnóstico, la relación entre el nivel cultural del paciente y la actividad, la agregación familiar, el fenotipo (extensión y tipos clínicos), el número de ingresos y estancias medias por año, las necesidades quirúrgicas y la mortalidad. PACIENTES Y MÉTODO: Se estudiaron 595 pacientes diagnosticados de enfermedad inflamatoria intestinal crónica según los criterios de Lennard-Jones, Truelove y Ashley B. Price. Realizamos un estudio epidemiológico descriptivo, poblacional, retrospectivo (1954-1993) y prospectivo (1994-1997) en el Área Sanitaria V de Gijón (Asturias) con 225.798 habitantes.

Resultados

Se estudiaron 595 pacientes con enfermedad inflamatoria intestinal crónica, de los cuales 305 (51,3%) padecían colitis ulcerosa, 272 (45,7%) enfermedad de Crohn y 18 (3%) colitis indeterminada. Un total de 287 (48,2%) pacientes eran mujeres y 308 (51,8%) varones, con una relación varón/mujer de 1,07. La media de edad en el momento del diagnóstico fue de 38,79 ± 17,44 (colitis ulcerosa: 43,37 ± 17,55; enfermedad de Crohn: 33,98 ± 16,16; colitis indeterminada: 33,73 ± 13,48; p = 0,000). La edad de inicio de síntomas previos al diagnóstico fue, para la colitis ulcerosa, de 42,03 años, para la enfermedad de Crohn, de 30,47 años y para la colitis indeterminada, de 30,99 años (p = 0,000). El diagnóstico se estableció en la colitis ulcerosa mediante criterios clínicos en el 99,01% de los casos (p = NS), criterios endoscópicos en el 95,04% (p = 0,000) y criterios histológicos en el 87,21% (p = 0,000); en la enfermedad de Crohn mediante criterios radiológicos en el 85,29% de los casos (p = 0,000). En cuanto al nivel de estudios superiores, en la colitis ulcerosa fue del 29,1% y en la enfermedad de Crohn del 66,7% (p = 0,0005). La asociación familiar fue del 9,8%. La extensión, para la colitis ulcerosa, fue: proctitis 21%, colitis distal 28,2%, colitis izquierda 22,3%, colitis extensa 4,2% y pancolitis 24%; en la enfermedad de Crohn, el 32,72% presentaban afección de íleon terminal, el 19,11% afección del colon, el 37,13% del colon y el intestino, el 11,02% con afecciones intestinales extensas y el 3,67% enfermedad gastroduodenal. La media de enfermos ingresados (1994-1997) con colitis ulcerosa fue del 8,37% y con enfermedad de Crohn del 14,51%; la estancia media global en la colitis ulcerosa fue de 1,63 días y en la enfermedad de Crohn de 2,27 días. La media de intervenciones quirúrgicas necesarias para el control de la enfermedad fue de 0,54 ± 1,08 (31,59% de los enfermos); para la colitis ulcerosa de 0,11 ± 0,36 (10,2%) y para la enfermedad de Crohn de 1,04 ± 1,38 (56,25%); p = 0,000. La tasa de mortalidad fue 48,73 fallecimientos/1.000 habitantes (colitis ulcerosa: 65,57; enfermedad de Crohn: 33,08, y ningún caso para la colitis indeterminada; p = NS). La ratio de mortalidad estándar fue de 4,83 (colitis ulcerosa: 6,51 y enfermedad de Crohn: 3,28).

Conclusiones

Destacamos la uniformidad de distribución de la enfermedad en relación a los tipos y el sexo. Confirmamos un mayor nivel sociocultural sólo para los enfermos con enfermedad de Crohn. En estas enfermedades, las influencias genéticas son importantes y se observa una agregación familiar elevada, más relevante en la enfermedad de Crohn. Las complicaciones en este grupo de enfermos son poco frecuentes, destacando una mayor morbilidad para la enfermedad de Crohn reflejada en los requerimientos quirúrgicos e ingresos, pero, sin embargo, con una menor mortalidad que en la colitis ulcerosa.

Aims

To determine several aspects of the epidemiology of chronic inflammatory bowel disease (IBD), including distribution of the various forms of IBD, sex, age at diagnosis considering lag-time to diagnosis, criteria used in the diagnosis, the relationship between educational level and acti-vity, familial aggregation, phenotype (site and clinical type), number of admissions and mean hospital stay/year, surgical requirements and mortality.

Patients And Methods

We carried out a retrospective (1954-1993) and prospective (1994-97) descriptive epidemiologic population study, in the fifth health district of Gijón in Asturias (Spain), with 225,798 inhabitants. A total of 595 patients diagnosed with chronic IBD according to the diagnostic criteria described by Lennard-Jones and Truelove for Crohn's disease (CD) and ulcerative colitis (UC) and according to Ashley B. Price's criteria for indeterminate colitis (IC) were studied. In all patients a complete clinical followup was performed.

Results

During the study period, we diagnosed 595 patients with IBD [305 patients with UC (51.3%), 272 (45.7%) patients with CD and 18 (3%) with IC]. Sex distribution was 287 females (48.2%) and 308 males (51.8%), with a male/female ratio of 1.07. Mean age at presentation was 38.79 ± 17.44 years (UC: 43.37 ± 17.55; CD: 33.98 ± 16.16; IC: 33.73 ± 13.48), p = 0.000. Age at onset prior to diagnosis was as follows: UC: 42.03; CD: 30.47; IC: 30.99 (p = 0.000). Diagnostic criteria used in UC was symptomatic in 99.01% (p = ns), endoscopic in 95.04% (p = 0.000), and pathologic in 87.21% (p = 0.000); in CD diagnostic criteria used was radiologic in 85.29% (p = 0.000). A total of 29.1% of patients with UC and 66.7% of those with CD had higher education (p = 0.0005). Family history was found in 9.8%. Anatomical site was as follows: in UC: rectum 21%, 28.2% rectum and sigmoid, 22.3% left colitis, 4.2% distal to hepatic flexure and 24% pancolitis; in CD: 32.72% terminal ileum, 19.11% colon, 37.13% ileo-colon, 11.02% extensive intestinal and 3.67% gastro-duodenal. A total of 8.37% of patients with UC and 14.51% of those with CD had been hospitalized during the previous 4 years; mean hospital stay was 1.63 days in UC and 2.27 days in CD. The mean surgical requirements were 0.54 ± 1.08 (31.59%); UC: 0.11 ± 0.36 (10.2%); CD: 1.04 ± 1.38 (56.25%), p = 0.000. The mortality rate was 48.73 deaths/1,000 inhabitants (UC: T = 65.57; CD: T = 33.08; IC:T= 0) p = ns. The standardized mortality ratio was 4.83 (UC: 6.51; CD: 3.28).

Conclusions

We highlight the uniformity of the distribution of IBD in relation to types of disease and sex. Patients with CD had a higher level of education. Genetic components play an important role in these diseases and familial aggregation was high, especially in CD. Complicated situations are infrequent in this group of patients. Morbidity was higher in patients with CD as reflected by surgical requirements and hospital stay. Mortality was lower in CD than in UC.

Full text is only aviable in PDF
Bibliografía
[1.]
J.G. Evans, E.D. Acheson.
An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area.
Gut, 6 (1965), pp. 311-324
[2.]
B. Price Ashley.
Overlap in the spectrum of non-specific inflammatory bowel disease «Colitis Indeterminate».
J Clinic Pathol, 31 (1978), pp. 567-577
[3.]
J.E. Lennard-Jones.
Regional enteritis (Crohn`s disease): definition and diagnosis. Skandia International Symposia: Regional Enteritis.
pp. 108-109
[4.]
J.E. Lennard-Jones.
Classification of inflammatory bowel disease.
Scand J Gastroenterol, 24 (1989), pp. 2-4
[5.]
S.C. Truelove, C. Witts.
Cortisone in ulcerative colitis.
Br Med J, 2 (1955), pp. 1041-1048
[6.]
C. Saro Gismera, M. Lacort Fernández, G. Argüelles Fernández, J. Antón Magarzo, R. García López, C. Navascues, et al.
Incidencia y prevalencia de la enfermedad inflamatoria intestinal crónica en Gijón. Asturias.
Gastroenterol y Hepatol, 23 (2000), pp. 322-327
[7.]
L.E. Hugues.
Cinical classification of perineal Crohn`s disease.
Dis Colon Rectum, 35 (1992), pp. 928-932
[8.]
J. Hinojosa, J. Primo, S. Lledó, A. López, J.V. Roig, J. Fernández.
Incidencia de enfermedad inflamatoria intestinal en Sagunto.
Rev Esp Enferm Ap Digest, 78 (1990), pp. 283-287
[9.]
R. Solá Lamoglia, A.M. García-Pugués, J. Monés Xiol, C. Badosa Gallart, J. Badosa Gallart, a.l. Casellas F el.
Enfermedad inflamatoria crónica intestinal en Cataluña (Barcelona y Gerona).
Rev Esp Enferm Ap Digest, 81 (1992), pp. 7-14
[10.]
E. Brullet, M. Rue, A. Monserrat, M. Gil, A. Malet, P. Mas, et al.
Estudio epidemiológico descriptivo de la colitis ulcerosa en un hospital comunitario (1985-1989).
Med Clin Barc, 97 (1991), pp. 45-49
[11.]
J. Maté Jiménez, S. Muñoz, D. Vicent, J.M. Pajares.
Incidence and prevalence of ulcerative colitis and Crohn's disease in urban and rural areas of Spain from 1981 to 1988.
J Clin Gastroenterol, 18 (1994), pp. 27-31
[12.]
E. Brullet, X. Bonfill, G. Urrutia, V. Ruiz Ochoa, M. Cueto, J. Clofent, et al.
Estudio epidemiológico sobre la incidencia de la enfermedad inflamatoria intestinal en cuatro áreas españolas.
Med Clin (Barc), 110 (1998), pp. 651-656
[13.]
S. Shivananda, J. Lennard-Jones, R. Logan, N. Fear, A. Price, L. Carpenter, et al.
Incidence of inflammatory bowel disease across europe: is there a difference between north and south?.
Result of the European Collaborative Study on inflammatory bowel disease. Gut, 39 (1996), pp. 690-697
[14.]
C. Gower Rousseau, J.L. Salomez, J.L. Dupas, R. Marti, M.C. Nuttens, A. Votte, et al.
Incidence of inflammatory bowel disease in northem France (1988-1990).
Gut, 35 (1994), pp. 1433-1438
[15.]
E. Langholz, P. Munkholm, O.H. Nielsen, S. Kreiner, V. Binder.
Incidence and prevalence of ulcertive colitis in Copenhagen county from 1962 to 1987.
Scand J Gastroenterol, 26 (1991), pp. 1247-1256
[16.]
P. Latour, J. Belaiche, E. Louis, F. Fontaine, J. Deflandre, J. Loly, et al.
Incidence of inflammatory bowel disease in the province of Liege (Belgium). La Societe de Gastroenterologie Liegeoise.
Acta Gastroenterol Belg, 59 (1996), pp. 3-6
[17.]
S. Shivananda, A.S. Peña, M. Nap, I.T. Weterman, J.F. Mayberry, a.l. Ruitenberg EJ el.
Epidemiology of Crohn's disease in regio Leiden, The Netherlands. A population based study from 1979-1983.
Gastroenterology, 93 (1987), pp. 966-974
[18.]
O.N. Manousos, I. Koutroubakis, S. Potamianos, M. Oussomoustakaki, N. Gourtsoyiannis, I.G. Vlachonikolis.
A prospective epidemiologic study of Crohn's disease in Heraklion, Crete. Incidence over a 5-year period.
Scand J Gastroenterol, 31 (1996), pp. 599-603
[19.]
A. Tragnone, G. Corrao, F. Miglio, R. Caprilli.
Lanfranchi GA and Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Incidence of inflammatory bowel disease in Italy: a nationwide population-based study.
Int J Epidemiol, 25 (1996), pp. 1044-1052
[20.]
C. Gower-Rousseau, B. Grandbastien, A. Cortot, J.F. Colombel.
Epidemiology of inflammatory bowel disease: is there a «Belgian-French exception?.
» Acta Gastroenterol Belg, 59 (1996), pp. 2
[21.]
J. Cella Lanau, J. López Zaborras, F. Gomollón García, R. Sáinz Samitier.
Enfermedad inflamatoria intestinal en Aragón: un diagnóstico cada vez más frecuente.
Rev Esp Enferm Ap Digest, 87 (1995), pp. 363-367
[22.]
S. Kildebo, K. Nordgaard, O. Aronse, R. Breckan, P.G. Buhol, R. Jorde, et al.
The incidence of ulcertive colitis in Northern Norway from 1983 to 1986. The Northern Norwegian Gastroenterology Society.
Scand J Gastroenterol, 25 (1990), pp. 890-896
[23.]
C. Tysk, G. Järnerot.
Ulcerative proctocolitis in Örebro, Sweden. A retrospective epidemiologic study, 1963-1987.
Scand J Gastroenterol, 27 (1992), pp. 945-950
[24.]
R. Monferrer Guardiola, J.A. Martín Jiménez, R.G. Pedraza Sanz, I. Moreno Sánchez, E. Soler Bahillo, J. Hinojosa del Val.
Incidencia de la enfermedad inflamatoria intestinal en el Área de Salud 02 de Castellón (1992-1996).
Rev Esp Enferm Digest, 91 (1999), pp. 33-39
[25.]
J. Stewenius, I. Adnerhill, G. Ekelund, C-H Florén, F-T Fork, L. Janzon, et al.
Ulcerative colitis and indeterminate colitis in the City of Malmö, Sweden. A 25-year incidence study.
Scand J Gastroenterol, 30 (1995), pp. 38-43
[26.]
C. Gasche, J. Schölmerich, J. Brynskov, G. D'Haens, S.B. Hanauer, E.J. Irvine, et al.
The Vienna Classification of Crohn's disease.
Consensus of the international Working Party for the World Congresses of Gastroenterology, (1998), pp. 35-42
[27.]
S. Radhakrishnan, G. Zubaidi, M. Daniel, G.K. Sachdev, A.N. Mohan.
Ulcerative colitis in Oman. A prospective study of the incidence and disease pattern from 1987 to 1994.
Digestion, 58 (1997), pp. 266-270
[28.]
A. Pera, P. Bellando, D. Caldeiro, V. Ponti, M. Astegiano, C. Barletti, et al.
Colonoscopy in inflammatory bowel disease.
Gastroenterology, 92 (1987), pp. 181-185
[29.]
Spanish Epidemiological and Economic Study Group on Crohn's disease..
Epidemiological and clinical features of Spanish patients.
Eur J Gastroenterol Hepatol, 11 (1999), pp. 1121-1127
[30.]
A. Van Gossum, M. Adler, M. De Reuck, G. Devis, R. Fiasse, R. Vanheurverzwijn, et al.
Epidemiology of inflammatory bowel disease in Brussels' area (1992-1993).
Acta Gastroenterol Belg, 59 (1996), pp. 7-9
[31.]
D. Heresbach.
Anticipation in Crohn's disease may be influenced by gender and ethnicity of the transmitting parent.
Am J Gastroenterol, 93 (1998), pp. 2368-2372
[32.]
B. Grandbastien.
Anticipation in familial Crohn's disease.
Gut, 42 (1998), pp. 170-174
[33.]
M. Peeters, H. Nevens, F. Baert, M. Hiele, A.M. de Meyer, R. Vlietinck, et al.
Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics.
Gastroenterology, 111 (1996), pp. 597-603
[34.]
M.C. Comes, C. Gower Rousseau, J.F. Colombel, J. Belaïche, H.J. Van Kruiningen, M.C. Nuttens, et al.
Inflammatory bowel disease in married couples: 10 cases in nord Pas de Calais region on France and Liege country of Belgium.
Gut, 35 (1994), pp. 1316-1318
[35.]
F. Tavarela Veloso, J. Fraga, J. Carvalho.
Inflammatory bowel disease in Oporto. A prospective hospital study.
Scand J Gastroenterol, 24 (1989), pp. 32-35
[36.]
G. Meuci, M. Vechii, G. Torgano, T. Arrigonia, A. Prada, F. Rocca, et al.
Familiar aggregation of inflammatory bowel disease in Northern Italy. A multicenter study.
Gastroenterology, 103 (1992), pp. 504-519
[37.]
T.M. Bayless, A. Tokayer, J.M. Polito II, S.A. Quaskey, E.D. Mellits, M.L. Harris.
Crohn's disease: concordance for site and clinical type in affected family members-potential hereditary influences.
Gastroenterol, 111 (1996), pp. 573-579
[38.]
U. Monsén, O. Bernell, C. Johansson, G. Hellers.
Prevalence of inflammatory bowel disease among relatives of patients with Crohn's Disease.
Scand J Gastroenterol, 26 (1991), pp. 302-306
[39.]
D.B. Sachar, H.A. Andrews, R.G. Farmer, F. Pallone, A.S. Peña, C. Prantera, et al.
Proposed classification of patient subgroups in Crohn's Disease.
Gastroenterol Int, 5 (1992), pp. 141-154
[40.]
J.E. Lennard-Jones, S. Shivananda.
and the RC-IBD Study Group. Clinical uniformity of inflammatory bowel disease at presentation and during the first year of disease in the North and the South of Europe.
Eur J Gastroenterol Hepatol, 9 (1997), pp. 353-359
[41.]
N. Hiwatashi, T. Yao, H. Watanabe, S. Hosoda, K. Kobayashi, T. Saito, et al.
Long-term follow-up study of ulcerative colitis in Japan.
Gastroenterology, 30 (1995), pp. 13-16
[42.]
A. Ekbom, C.G. Helmick, M. Zack, L. Holmberg, H.O. Adami.
Survival and causes of death in patients with inflammatory bowel disease: a population-based study.
Gastroenterology, 103 (1992), pp. 954-960
[43.]
P.G. Persson, O. Bernel, C.E. Leijonmarck, et al.
Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study.
Gastroenterology, 110 (1996), pp. 1339-1345
[44.]
I.T. Weterman, I. Biemond, AS. Peña.
Mortality and causes of death in Crohn's disease. Review of 50 years experience in Leiden University Hospital.
Gut, 31 (1990), pp. 1387-1390
[45.]
O. Brostrom, U. Monsen, B. Nordenwall, J. Sorstad, G. Hellers.
Prognosis and mortality of ulcerative colitis in Stockholm Country,1955-1979.
Scand J Gastroenterol, 22 (1987), pp. 907-913
[46.]
P. Munkholm, E. Langholz, M. Davidsen, V. Binder.
Intestinal cancer risk and mortality in patients with Crohn's disease.
Gastroenterology, 105 (1993), pp. 1716-1723
[47.]
C.S. Probert, V. Jayanthi, A.C. Wicks, J.F. Mayberry.
Mortality in patients with ulcerative colitis in Leicestershire, 1972-1989. An epidemiological study.
Dig Dis Sci, 38 (1993), pp. 538-541
[48.]
C. Saro Gismera, L. Lacort Fernández, G. Argüelles Fernández, J.L. Anton Magarzo, A. Suárez González, R. García López, et al.
Mortalidad y causas de muerte en enfermedad inflamatoria intestinal crónica. Gijón. Asturias.
Rev Esp Enferm Digest, 91 (1999), pp. 199-203
Copyright © 2001. Elsevier España, S.L.. Todos los derechos reservados
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos